MGO Verified Catalog ISO 17025 NZ MPI Certified

Certified High-MGO Reserves

This catalog presents independently laboratory-verified Manuka honey reserves selected for methylglyoxal (MGO) concentration and origin traceability. All products listed meet dual-stage ISO 17025 testing requirements. Procurement links are direct vendor references verified against published certification data.

Review the Methylglyoxal Science

Verification Standards

Dual-Stage Lab Testing MGO concentration confirmed at harvest and post-processing
Monofloral Origin Pollen count verification confirming Leptospermum scoparium dominance
NZ MPI Compliance Meets New Zealand Ministry for Primary Industries export standards
Batch Chain of Custody Harvest origin, processing facility, and test certificate linked per batch

Market Benchmarks: Clinical Potency Tiers

The following tiers represent commercial benchmarks for pharmaceutical and clinical procurement. Methylglyoxal concentration is the primary driver for therapeutic classification and pricing. Figures reference 250g unit retail pricing from the 2026 Manuka Health NZ and Wedderspoon product catalogs.

Pharmaceutical Grade 800+

Research applications, advanced wound protocols, recalcitrant biofilm environments. Target populations: chronic wound beds with confirmed bacterial resistance.

Clinical Grade 400+

Primary wound care applications, antimicrobial dressing base, post-surgical prophylaxis. Meets Cardiff Wound Innovation Centre minimum threshold recommendations.

Daily Functional <400

Daily prophylactic use, oral health support, general antimicrobial maintenance. Below the minimum threshold for acute wound care applications.

This catalog does not feature individual wellness-tier products. See the Varietal Honey Reference for multifloral options.

Retail Price Reference: Manuka Health New Zealand and Wedderspoon Organic 2026 product catalogs. Figures represent 250g unit benchmarks in USD. See our affiliate disclosure policy for full details.

Primary Catalog

Manuka Health New Zealand

Manuka Health NZ operates proprietary apiaries across Northland, Waikato, and Hawke's Bay. Each product listed below carries an individual certificate of analysis. Batch codes and laboratory verification dates are rendered dynamically from our internal verification registry.

View Full Catalog

Pharmaceutical Grade 800+

Clinical Indication: Peak bioactivity reserve. For pharmaceutical-grade antimicrobial research and advanced, recalcitrant wound environments where standard MGO thresholds are insufficient.
Confirmed Threshold: 1,600 mg/kg methylglyoxal minimum, verified post-processing
Certification: ISO 17025 Dual-Stage Laboratory Testing
Origin: Monofloral, New Zealand MPI Export Certified

$575.00 View Specs

Clinical Indication: High-potency clinical reserve for acute wound care, confirmed biofilm environments, and institutional procurement requiring documented potency certification.
Confirmed Threshold: 1,000 mg/kg methylglyoxal minimum, verified post-processing
Certification: ISO 17025 Dual-Stage Laboratory Testing
Origin: Monofloral, New Zealand MPI Export Certified

$200.00 View Specs

Clinical Indication: Single-site origin reserve from the Pohuenui station, Hawke's Bay. Recommended where chain-of-custody requires specific apiary provenance, not just regional origin.
Confirmed Threshold: 856 mg/kg methylglyoxal minimum, single-origin verified
Certification: ISO 17025 with single-apiary traceability certificate
Origin: Monofloral, Pohuenui Station, Hawke's Bay, NZ

$275.00 View Specs

Clinical Grade 400+

Clinical Indication: Upper clinical tier. Suitable for primary wound dressing, antimicrobial barrier maintenance, and institutions requiring documentation at or above 800 mg/kg.
Confirmed Threshold: 800 mg/kg methylglyoxal minimum
Certification: ISO 17025 Dual-Stage Laboratory Testing
Origin: Monofloral, New Zealand MPI Export Certified

$100.00 View Specs

Clinical Indication: Clinical standard for wound care protocols requiring documented antimicrobial activity. Appropriate for most acute wound applications and maintenance dressing cycles.
Confirmed Threshold: 600 mg/kg methylglyoxal minimum
Certification: ISO 17025 Dual-Stage Laboratory Testing
Origin: Monofloral, New Zealand MPI Export Certified

$75.00 View Specs

Clinical Indication: Entry-point bundle for clinical trial and patient education contexts. Bundles MGO 600+ with supporting documentation. Suitable for initiating wound care protocols.
Confirmed Threshold: 600 mg/kg methylglyoxal minimum
Certification: ISO 17025 Dual-Stage Laboratory Testing
Origin: Monofloral, New Zealand MPI Export Certified

$75.00 View Specs

Clinical Indication: Wound care entry threshold. Minimum potency recommended per published clinical guidelines. Suitable for low-exudate wound beds and prophylactic use.
Confirmed Threshold: 400 mg/kg methylglyoxal minimum
Certification: ISO 17025 Dual-Stage Laboratory Testing
Origin: Monofloral, New Zealand MPI Export Certified

$60.00 View Specs

Clinical Indication: Daily prophylactic and oral health support. Below the acute wound care threshold but suitable for patient wellness protocols and supplementation maintenance.
Confirmed Threshold: 300 mg/kg methylglyoxal minimum
Certification: ISO 17025 Dual-Stage Laboratory Testing
Origin: Monofloral, New Zealand MPI Export Certified

$35.00 View Specs

Adjunct Protocol: Propolis

Bio30 Propolis is included as a reference product for practitioners integrating multi-compound antimicrobial protocols. Propolis flavonoids demonstrate synergistic antimicrobial activity alongside MGO in published in-vitro literature. This is not a wound-contact product.

Clinical Indication: Oral antimicrobial adjunct. Standardized to 30mg bio-available flavonoids per capsule. Referenced in literature for synergistic action with Manuka honey in systemic protocols.
Active Compound: Bio30 standardized propolis extract, 30mg flavonoids per capsule
Administration: Oral, 1 capsule daily. Not a topical wound product.
Origin: Standardized propolis extract, Manuka Health NZ

$75.00 View Specs

Reference Catalog

Wedderspoon Mānuka Honey

Wedderspoon provides cost-accessible clinical tier options with consistent ISO 17025 verification. Listed here as a reference standard for institutions with volume procurement requirements at lower per-unit cost. Products carry KFactor and MGO dual-certification.

View Full Catalog

Clinical Indication: High-potency pharmaceutical-tier reference product. Suitable for clinical protocols requiring verified MGO above 1000 mg/kg at accessible price per unit.
Confirmed Threshold: 1,100 mg/kg methylglyoxal minimum
Certification: ISO 17025 / KFactor & MGO Dual Certification
Origin: Raw Monofloral, New Zealand MPI Certified

$124.99 View Specs

Clinical Indication: Volume-accessible option for wound care dressing protocols. Suitable for departments requiring documented MGO certification at institutional quantity.
Confirmed Threshold: 850 mg/kg methylglyoxal minimum
Certification: ISO 17025 / KFactor & MGO Dual Certification
Origin: Raw, New Zealand MPI Certified

From $79.99 View Specs

Supporting Science

Methylglyoxal Antibacterial Science Biofilm Disruption Research Medical Grade Standards Terroir & Origin Research

Certified High-MGO Reserves

Verification Standards

Market Benchmarks: Clinical Potency Tiers

Manuka Health New Zealand

Manuka Honey Pinnacle Harvest MGO 1600+

Manuka Honey Reserve MGO 1000+

Manuka Honey Single Origin Pohuenui MGO 856+

Manuka Honey Ultra MGO 800+

Manuka Honey Extra MGO 600+

Manuka Health MGO 600+ Kit

Manuka Honey Daily MGO 400+

Manuka Honey Classic MGO 300+

Bio30 Propolis 1-a-Day 90 Capsules

Wedderspoon Mānuka Honey

Raw Monofloral Mānuka MGO 1100+

Raw Mānuka Honey MGO 850+

Supporting Science